This describes the clinical characteristic of a therapeutic agent that is highly specific in its action, targeting only the intended receptor or pathway with minimal off-target effects. Achieving high signal precision minimizes systemic disruption and reduces the likelihood of unwanted side effects. This is a hallmark of advanced, targeted pharmaceutical development, particularly in peptide and hormone analogs.
Origin
The term originates in molecular pharmacology and drug design, where the goal is to maximize the therapeutic index by increasing selectivity. In the context of hormonal health, it reflects the shift from broad-acting compounds to highly refined molecules that mimic natural signaling with fidelity. This precision is essential for long-term safety and efficacy.
Mechanism
A drug with high signal precision exhibits a strong affinity and intrinsic activity for its primary receptor, such as a specific growth hormone secretagogue receptor, while showing negligible affinity for related receptors like those for prolactin or cortisol. This targeted mechanism ensures that the desired physiological effect, such as pulsatile GH release, is achieved without perturbing other delicate endocrine axes.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.